PTIE Pain Therapeutics gains 16% Oct 3, 2017

Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company's lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimer's disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas. http://www.priceseries.com/trade/PTIE-Pain-Therapeutics-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017091320171003.html